|
NextRegenX
|
Medikan Co., Ltd.
|
Automated stem cell separation device (STEM-XE One), Integrated adipose tissue aspiration system (Lipokit Neo), Device that fragments adipose tissue to create Fat Gel (FillerGeller), Cell storage and preservation with automated cryogenic freezing (CryoHybrid), Convenient multi-filtration system to isolate high-purity exosomes (X-Trap), Remote-observable cell culture device (Storage Box P)
|
B41
|
|
NextRegenX
|
MEDVIA CO., LTD.
|
Regulatory Affairs and Clinical Strategy
|
C26
|
|
NextRegenX
|
MEPSGEN
|
(1) MEPS-TBC-WL, (2) MEPS-TBC-CH, (3) MEPS-ORD, (4) ProMEPS™, (5) NanoCalibur™ Lab
|
A22
|
|
PARTNERING
|
Micromediome
|
Microbiome-Based Adjuvant for Radiotherapy & Immuno-Oncology via TME Modulation
|
E41
|
|
PARTNERING
|
Mitos Therapeutics Inc.
|
Treatment of Sarcopenia
|
E41
|
|
PARTNERING
|
MolGenBio Co., Ltd.
|
MolGenBio is developing a novel proprietary synthetic biology platform technology targeting intractable diseases such as neurodegenerative diseases and cancer. Our innovative and robust platform technology aims to develop the first/best-in-class small molecule therapeutics by harnessing the expertise in microbial genome scanning, editing and assembly. Our proprietary MTG (Molecule Through Gene) platform enables us to generate structural derivatives of small molecule drug candidates that are difficult to synthesize through the conventional medicinal chemistry approach. Our CEO/founder Prof Yoon at Seoul National University elucidated the complete biosynthetic pathway of FK506 for the first time. MolGenBio team has world-class expertise in tacrolimus R&D/manufacturing.
|
E41
|
|
KOREA LIFE SCIENCE
|
MS Automation
|
Imaging Module
|
C56
|
|
KOREA LIFE SCIENCE
|
MyMedics Co.,Ltd.
|
Auto-Cpap, Oxygen Concentrator, Cpap Supplies.
|
E46
|
|
PARTNERING
|
Nanofaentech Co.,Ltd.
|
3D Cell culture plate and primary DC Preparation
|
C60
|
|
NextRegenX
|
Nature Cell Co.,Ltd.
|
Stem cell therapy
|
B12
|
KYUNGYON EXHIBITION CORP.